Roel Bulthuis (pictured), managing director of Merck Ventures, spoke to Kaloyan Andonov about the evolution of the venturing fund, which has increased its capital commitment and its investment scope beyond healthcare and pharmaceuticals

Kaloyan Andonov spoke with Andrew Pitz, an associate at Transamerica Ventures, a New York firm that acts as the corporate venturing unit of Netherlands-based Aegon Insurance and its US-based subsidiary, Transamerica Life Insurance.

Marcos Battisti, who used to oversee Intel Capital's Western Europe and Israel activity, is joining VC firm C5 Capital as it looks to raise a $150m cloud computing fund.

2015 saw companies raising large VC rounds faster and investors existing quicker, according to Jon Norris of Silicon Valley Bank, and expect M&A to stay steady as IPO market continues to move slowly.

Corporates remained active as crossover investors helped take healthcare VC investment to its highest level since 2000, Jonathan Norris of Silicon Valley Bank told Global Corporate Venturing.